Patents by Inventor Rikke Høegh Lorentsen
Rikke Høegh Lorentsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10550375Abstract: The present invention relates to an isolated polypeptide having xylanase activity, selected from the group consisting of: a) a polypeptide comprising an amino acid sequence having at least 87% identity with SEQ ID NO: 1; b) a polypeptide encoded by a polynucleotide having at least 87% identity with SEQ ID NO:2; or c) a fragment of a polypeptide of a) or b) which fragment has xylanase activity.Type: GrantFiled: January 30, 2015Date of Patent: February 4, 2020Assignee: DuPont Nutrition Biosciences ApSInventors: Rikke Hoeegh Lorentsen, Susan Arent Lund, Svend Haaning, Igor Nikolaev, Sharief Barends, Jan Hendrick A Van Tuijl, Bart Koops
-
Patent number: 10253304Abstract: The present invention provides hemicellulytic enzyme variants. Specifically, the present invention provides xylanase variants having one or more modifications as compared to a parent xylanase enzyme resulting in at least one improved property. In addition, the present invention provides compositions comprising a xylanase variant of the invention. The present invention also provides methods of degrading hemicellulotic material, including arabino-xylan using compositions comprising a xylanase variant of the invention.Type: GrantFiled: January 30, 2015Date of Patent: April 9, 2019Assignee: DUPONT NUTRITION BIOSIENCES APSInventors: Rikke Hoeegh Lorentsen, Susan Arent Lund, Jacob F. Cramer, Igor Nikolaev, Wilhelmus Van Der Kleij
-
Patent number: 10165787Abstract: A GH10 xylanase variant is disclosed herein. This GH10 xylanase variant has increased thermostability compared with a parent GH10 xylanase enzyme comprising at least 90% sequence identity with the amino acid sequence of SEQ ID No. 1 wherein the variant has been modified at two or more of the following positions 7, 33, 79, 217 and 298 corresponding to the amino acid numbering of SEQ ID No. 1.Type: GrantFiled: January 30, 2015Date of Patent: January 1, 2019Assignee: DUPONT NUTRITION BIOSCIENCES APSInventors: Rikke Hoeegh Lorentsen, Susan Arent Lund, Igor Nikolaev, Jan Hendrik A. Van Tuijl, Bert Koops
-
Publication number: 20170009220Abstract: The present invention relates to an isolated polypeptide having xylanase activity, selected from the group consisting of: a) a polypeptide comprising an amino acid sequence having at least 87% identity with SEQ ID NO: 1; b) a polypeptide encoded by a polynucleotide having at least 87% identity with SEQ ID NO:2; or c) a fragment of a polypeptide of a) or b) which fragment has xylanase activity.Type: ApplicationFiled: January 30, 2015Publication date: January 12, 2017Applicant: DuPont Nutrition Biosciences ApSInventors: Rikke Hoeegh Lorentsen, Susan Arent Lund, Svend Haaning, Igor Nikolaev, Sharief Barends, Jan Hendrick A Van Tuijl, Bert Koops
-
Publication number: 20160345609Abstract: The present inventions relates to a modified GH10 xylanase enzyme or a fragment thereof having xylanase activity wherein said modified GH10 xylanase or fragment thereof has increased thermostability compared with a parent GH10 xylanase enzyme, the parent GH10 xylanase having been modified at, at least, two of the following positions 7, 33, 79, 217 and 298, wherein the numbering is based on the amino acid numbering of FveXyn4 (SEQ ID No. 1). In particular, the modified xylanase enzyme according to the present invention has the following modifications: N7D; T33V; K79Y, V, F, I, L or M (preferably K79Y, F or V, more preferably Y); A217Q, E, P, D or M (preferably A217Q, E or P, more preferably Q); and T298Y, F or W (preferably Y or F, more preferably Y).Type: ApplicationFiled: January 30, 2015Publication date: December 1, 2016Inventors: Rikke Hoeegh Lorentsen, Susan Arent Lund, Igor Nikolaev, Jan Hendrik A. Van Tuijl, Bert Koops
-
Publication number: 20160345595Abstract: A process for the preparation of a corn-based foodstuff, the process comprising the step of contacting a corn-based flour with a xylanase enzyme, as defined herein, such that a xylan-containing material native to the corn is degraded, is disclosed. Flours, masas and masa foodstuffs, especially tortillas, produced by the process are also disclosed.Type: ApplicationFiled: January 28, 2015Publication date: December 1, 2016Inventors: Pablo Kuri-Brena Romero De Terreros, Gerardo Avilez, Charlotte Poulsen, Rie Mejldal, Rikke Hoeegh Lorentsen
-
Patent number: 9382523Abstract: The present invention provides a transformed or transfected Trichoderma reesei cell comprising one or more of: (i) at least one heterologous nucleotide sequence encoding a lipolytic enzyme comprising an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO: 2, (ii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence shown as SEQ ID NO: 3 or SEQ ID NO: 4, or (iii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence which hybridizes to SEQ ID NO: 3 or SEQ ID NO: 4 or a nucleotide sequence which is at least 40% sequence identity to SEQ ID NO: 3 or SEQ ID NO: 4; and culturing the cell under conditions to allow for expression of the heterologous nucleotide sequence(s) encoding the lipolytic enzyme.Type: GrantFiled: November 7, 2014Date of Patent: July 5, 2016Assignee: DUPONT NUTRITION BIOSCIENCES APSInventors: Susan Madrid, Cherry Lin, Masoud Rajabi Zargahi, Rikke Høegh Lorentsen, Mai Faurschou Isaksen, Michael Ward
-
Publication number: 20150064309Abstract: The present invention provides a transformed or transfected Trichoderma reesei cell comprising one or more of: (i) at least one heterologous nucleotide sequence encoding a lipolytic enzyme comprising an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO: 2, (ii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence shown as SEQ ID NO: 3 or SEQ ID NO: 4, or (iii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence which hybridizes to SEQ ID NO: 3 or SEQ ID NO: 4 or a nucleotide sequence which is at least 40% sequence identity to SEQ ID NO: 3 or SEQ ID NO: 4; and culturing the cell under conditions to allow for expression of said heterologous nucleotide sequence(s) encoding said lipolytic enzyme.Type: ApplicationFiled: November 7, 2014Publication date: March 5, 2015Inventors: SUSAN MADRID, CHERRY LIN, MASOUD RAJABI ZARGAHI, RIKKE HØEGH LORENTSEN, MAI FAURSCHOU ISAKSEN, MICHAEL WARD
-
Patent number: 8940519Abstract: The present invention provides a transformed or transfected Trichoderma reesei cell comprising one or more of: (i) at least one heterologous nucleotide sequence encoding a lipolytic enzyme comprising an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO:2, (ii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence shown as SEQ ID NO: 3 or SEQ ID NO: 4, or (iii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence which hybridizes to SEQ ID NO: 3 or SEQ ID NO: 4 or a nucleotide sequence which is at least 40% sequence identity to SEQ ID NO: 3 or SEQ ID NO: 4; and culturing the cell under conditions to allow for expression of the heterologous nucleotide sequence(s) encoding the lipolytic enzyme.Type: GrantFiled: April 23, 2010Date of Patent: January 27, 2015Assignee: DuPont Nutrition Biosciences ApSInventors: Susan Madrid, Cherry Lin, Masoud Rajabi Zargahi, Rikke Høegh Lorentsen, Mai Faurschou Isaksen, Michael Ward
-
Patent number: 8445250Abstract: The present invention relates to a feed supplement comprising a phytase and a lipolytic enzyme, wherein said lipolytic enzyme has lipase activity at a pH in the range of about pH1.5 to about pH3.5.Type: GrantFiled: April 23, 2010Date of Patent: May 21, 2013Assignee: DuPont Nutrition BioSciences ApSInventors: Mai Faurschou Isaksen, Rikke Høegh Lorentsen, Peter Plumstead, Luis Fernando Romero Millán, Susan Madrid, Cherry Lin, Michael Ward, Masoud Rajabi Zargahi
-
Publication number: 20120196002Abstract: The present invention provides a transformed or transfected Trichoderma reesei cell comprising one or more of: (i) at least one heterologous nucleotide sequence encoding a lipolytic enzyme comprising an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO:2, (ii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence shown as SEQ ID NO: 3 or SEQ ID NO: 4, or (iii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence which hybridizes to SEQ ID NO: 3 or SEQ ID NO: 4 or a nucleotide sequence which is at least 40% sequence identity to SEQ ID NO: 3 or SEQ ID NO: 4; and culturing the cell under conditions to allow for expression of said heterologous nucleotide sequence(s) encoding said lipolytic enzyme.Type: ApplicationFiled: April 23, 2010Publication date: August 2, 2012Applicant: DANISCO A/SInventors: Susan Madrid, Cherry Lin, Masoud Rajabi Zargahi, Rikke Høegh Lorentsen, Mai Faurschou Isaksen, Michael Ward
-
Publication number: 20120107296Abstract: The present invention relates to a feed supplement comprising a phytase and a lipolytic enzyme, wherein said lipolytic enzyme has lipase activity at a pH in the range of about pH1.5 to about pH3.5.Type: ApplicationFiled: April 23, 2010Publication date: May 3, 2012Applicant: DANISCO A/SInventors: Mai Faurschou Isaksen, Rikke Høegh Lorentsen, Peter Plumstead, Luis Fernando Romero Millán, Susan Madrid, Cherry Lin, Michael Ward, Masoud Rajabi Zargahi
-
Patent number: 7960150Abstract: The present invention relates to a method for the production of a lipid acyltransferase comprising the steps of: (i) providing a Bacillus licheniformis cell; (ii) transforming the Bacillus licheniformis cell with a heterologous nucleotide sequence encoding a lipid acyltransferase; and (iii) expressing the lipid acyltransferase in the cell under the control of a promoter sequence. In addition, the present invention further relates to the use of Bacillus licheniformis to express a lipid acyltransferase, a Bacillus licheniformis host cell comprising a heterologous lipid acyltransferase and a vector comprising a nucleotide sequence encoding a lipid acyltransferase operably linked to a promoter sequence homologous to B. licheniformis.Type: GrantFiled: July 20, 2009Date of Patent: June 14, 2011Assignee: Danisco A/SInventors: Marc Kolkman, Jørn Dalgaard Mikkelsen, Rikke Høegh Lorentsen
-
Publication number: 20100081169Abstract: The present invention relates to a method for the production of a lipid acyltransferase comprising the steps of: (i) providing a Bacillus licheniformis cell; (ii) transforming the Bacillus licheniformis cell with a heterologous nucleotide sequence encoding a lipid acyltransferase; and (iii) expressing the lipid acyltransferase in the cell under the control of a promoter sequence. In addition, the present invention further relates to the use of Bacillus licheniformis to express a lipid acyltransferase, a Bacillus licheniformis host cell comprising a heterologous lipid acyltransferase and a vector comprising a nucleotide sequence encoding a lipid acyltransferase operably linked to a promoter sequence homologous to B. licheniformis.Type: ApplicationFiled: July 20, 2009Publication date: April 1, 2010Inventors: Marc Kolkman, Jørn Dalgaard Mikkelsen, Rikke Høegh Lorentsen